Issue 1246: May 18, 2016
Ask the Experts—Question of the Week: An expired dose of ProQuad (MMRV, Merck) was given to a patient. We assume…read more
TOP STORIES
VACCINE INFORMATION STATEMENTS
OFFICIAL RELEASES AND ANNOUNCEMENTS
WORLD NEWS
FEATURED RESOURCES
EDUCATION AND TRAINING
TOP STORIES
New! May 2016 issue of Needle Tips is now available online
The May 2016 issue of Needle Tips is now online.
Click on the image below to download the entire May issue of Needle Tips (24-page, 9.59 MB PDF).
Access the Table of Contents (HTML) to download individual sections or pages.
Related Links
If you would like to receive immediate email notification whenever new issues of Needle Tips or Vaccinate Adults are released, visit our Subscribe to IAC page to sign up.
Back to top
CDC offers resources about mumps targeted to college students and healthcare professionals
In response to recent outbreaks primarily affecting college campuses, CDC is offering the following new mumps resources on its mumps web page:
More information regarding recent outbreaks is available on CDC's Mumps Cases and Outbreaks web page.
Related Links
Back to top
Download Dr. Gary Marshall's The Vaccine Handbook: A Practical Guide for Clinicians (“The Purple Book") as a new app for iOS devices or purchase as a print book
The Vaccine Handbook: A Practical Guide for Clinicians (“The Purple Book,” 2015) is a comprehensive source of practical, up-to-date information for vaccine providers and educators. Its author, Gary S. Marshall, MD, has drawn together the latest vaccine science and guidance into a concise, user-friendly, practical resource for the private office, public health clinic, academic medical center, and hospital. This book is now available as a new app for iOS devices.
Information about the iOS app version of The Vaccine Handbook: A Practical Guide for Clinicians
The Vaccine Handbook App contains the 5th edition of the book, updated with the latest immunization schedules and recommendations. The app enhances the utility of an already valuable print resource by including functions like keyword search, internal links, bookmarking, quick access to schedules and tables, hyperlinks to external sources, and the ability for real-time updates. A resources section provides ready access to authoritative immunization-related websites. Available through a collaboration between the publisher and Sanofi Pasteur, registration as well as reporting under Open Payments is required. (Offer void in Minnesota.) Click on the image below to visit the relevant App Store page to download this resource today.
Information about the print version of The Vaccine Handbook: A Practical Guide for Clinicians
The fifth edition of this valuable guide (560 pages) is available on IAC's website at www.immunize.org/vaccine-handbook. The price of the handbook is $29.95 each, plus shipping charges. Discount pricing is available for more than 10 copies. Order copies for your staff or for distribution at an upcoming conference.
Quantity Discount Pricing
- 1–10 books: no discount + shipping
- 11–50 books: 5% + shipping
- 51–100 books: 10% + shipping
- 101–500 books: 15% + shipping
- 501–1000 books: 20% + shipping
For quotes on larger quantities, email admininfo@immunize.org.
Order your copy today! Click on the image below to visit the "Shop IAC: The Vaccine Handbook" web page.
About the Author
Gary Marshall, MD, is professor of pediatrics at the University of Louisville School of Medicine in Kentucky, where he serves as chief of the division of pediatric infectious diseases and director of the Pediatric Clinical Trials Unit. In addition to being a busy clinician, he is nationally known for his work in the areas of vaccine research, advocacy, and education.
Related Link
Back to top
IAC Spotlight! Free bulk quantities of pneumococcal and zoster vaccination laminated pocket guides now available from IAC for distribution within your organization
IAC is pleased to announce the availability of bulk quantities of two newly updated laminated pocket guides for use by healthcare professionals, yours free for the ordering! The guides address issues related to the administration of (1) pneumococcal conjugate (PCV13) and polysaccharide (PPSV23) vaccines and (2) zoster vaccine.
These concise pocket guides provide front-line healthcare personnel with quick reference information highlighting:
- Indications and contraindications for each vaccine
- Targeted populations to be vaccinated
- Details on how to administer the vaccines
- Talking points for discussions with patients
Each guide is laminated for durability, and the compact size (3¾" x 6¾") is designed to fit in a shirt or lab coat pocket.
The pocket guides are available at no cost to your organization. However, to assist us in controlling our mailing costs, we ask that you order in bulk (with a minimum order of 25) and that you manage the distribution of the guides (e.g., through internal channels, educational forums, member meetings, mass mailings) to your constituents.
To view the pocket guides and place your order, please visit www.immunize.org/pocketguides or click on either image below. These cards are for healthcare professional use only, not for distribution to patients.
Back to top
MMWR reports on Hepatitis Awareness Month and Hepatitis Testing Day
CDC published Hepatitis Awareness Month and Testing Day—2016 in the May 13 issue of MMWR (page 461). This May is the 21st Hepatitis Awareness Month and May 19 will be the fifth annual Hepatitis Testing Day. The report highlights disparities in hepatitis C incidence and mortality for American Indian/Alaska Native populations.
Related Links
Back to top
Vaccine Education Center releases Vax Pack Hero, a program designed for elementary-school age children
On May 11, the Vaccine Education Center at the Children's Hospital of Philadelphia (VEC) released Vax Pack Hero. The program, designed for elementary-age children, consists of a web-based game, physical trading cards, and an educational website. At VaxPackHero.org, children can play the video game, learn more about vaccine heroes, and find out about relevant germs. In the game, you are inside the body of a sick patient and must race against the clock to fend off the germs. Physical trading cards of all 50 Vaccine Heroes are also available for purchase at minimal cost.
Related Links
Back to top
Register now for an IAC “Take a Stand™" workshop on the use of standing orders in Boston, New York, Philadelphia, or Baltimore in June; related workshop to be offered at the Iowa Immunization Conference on June 15
The Immunization Action Coalition (IAC), with support from Pfizer, has implemented Take a Stand™, a national effort designed to improve adult immunization rates by increasing the use of standing orders in medical practices.*
At the core of this project are free workshops led by national experts, including L.J Tan, MS, PhD; William Atkinson, MD, MPH; and Deborah Wexler, MD, from IAC; and Alexandra Stewart, JD, from George Washington University. These workshops already have been conducted in Louisville, KY; Chicago, IL; Portsmouth, VA; Nashville, TN; Little Rock, AR; San Francisco, Sacramento, Los Angeles and San Diego, CA; Fort Worth, San Antonio, and Houston, TX; Seattle, WA; Phoenix and Tucson, AZ; Orlando and Fort Lauderdale, FL; and Atlanta, GA. To illustrate how these have been going, here is a small recent sampling of comments received from attendees:
"Take a Stand Workshop was excellent. It provided my organization with the resources and tools needed for a successful implementation." T.B., registered nurse, SD
"Phenomenal! Helped us learn what next steps to take for our organization and how to obtain buy-in from front line staff!" A.P., BSN, RN, CCP, clinical services coordinator, Sanford Health, SD
"It is interesting to know preventative care of adults is just as important as that of children, so 'take a stand' to get adults immunized. Standing orders are a smart/easy way to capture non-immunized adults. The workshop is very informative and engaging." L.S., clinical manager, GA
"All the speakers are extremely knowledgeable and engaging. It is among the top 3 BEST conference/workshops I've ever attended." S.B., immunization program coordinator, FL
Don’t miss your chance to join these satisfied attendees. The next workshops are scheduled in the following four cities:
In addition, a Take a Stand™ mini-workshop has been added to the Iowa Immunization Conference on June 15. For more information go to Mini-Session Take A Stand™ Davenport, Iowa. Note: attendees of the mini-workshop will need to register for the conference itself. The non-member registration fee is $100.
Be sure to note that these are one-time-only events in each city.
Who should attend? Clinicians, nurses, and practice managers in medical offices that serve adults, as well as pharmacists and quality improvement managers, will benefit from the workshops.
A sample agenda and online registration information are available on the Take a Stand™ website at www.standingorders.org.
Please “take a stand” with us and spread the word about this unique opportunity for medical practices to improve their adult immunization rates while empowering staff and streamlining facility operations.
* Standing orders are written protocols approved by a physician or other authorized practitioner that allow qualified healthcare professionals (who are eligible to do so under state law, such as registered nurses or pharmacists) to assess the need for vaccination and to vaccinate patients meeting certain criteria.
Workshop Information
Related Links
Back to top
VACCINE INFORMATION STATEMENTS
IAC posts four translations of the HPV9 VIS
IAC recently posted the following new translations of the HPV9 VIS dated March 31, 2016:
IAC thanks the California Department of Public Health for the translations.
Related Links
Back to top
OFFICIAL RELEASES AND ANNOUNCEMENTS
NIH news release announces that investigational malaria vaccine protected healthy U.S. adults for more than one year
On May 9, the National Institutes of Health (NIH) published Investigational malaria vaccine protects healthy U.S. adults for more than one year. A portion of the news release is reprinted below.
An experimental malaria vaccine protected a small number of healthy, malaria-naïve adults in the United States from infection for more than one year after immunization, according to results from a Phase 1 trial described in the May 9th issue of Nature Medicine. The vaccine, known as the PfSPZ Vaccine, was developed and produced by Sanaria Inc., of Rockville, Maryland, with support from several Small Business Innovation Research (SBIR) awards from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. NIAID researchers and collaborators at the University of Maryland School of Medicine in Baltimore, conducted the clinical evaluation of the vaccine, which involved immunization and exposing willing healthy adults to the malaria-causing parasite Plasmodium falciparum (P. falciparum) in a controlled setting.
Related Links
Back to top
WORLD NEWS
CDC and WHO report on global progress toward polio eradication in this week's MMWR and Weekly Epidemiological Report, respectively
CDC published Progress Toward Polio Eradication—Worldwide, 2015–2016 in the May 13 issue of MMWR (pages 470–473). On the same day, WHO published a similar article in Weekly Epidemiological Report titled Progress towards polio eradication worldwide, 2015–2016. A portion of the MMWR report is reprinted below.
Substantial gains toward polio eradication were made in 2015, with a 79% decrease in the number of polio cases reported worldwide compared with the number of cases reported in 2014. The removal of Nigeria from the list of countries with endemic polio in 2015 creates the opportunity for the African Region to join the Region of the Americas and the South-East Asia, Western Pacific, and European regions, as the fifth of six WHO regions to be certified free of indigenous WPV. Certification will occur after a minimum of 3 years of sensitive AFP surveillance. In addition, the Global Commission for the Certification of Poliomyelitis Eradication’s declaration of the eradication of WPV type 2 in 2015, and the absence of reported circulation of WPV type 3 since 2012, allows focus on WPV type 1 as the sole circulating type of WPV in the world, endemic only in Afghanistan and Pakistan. WHO considers the continued transmission of WPV type 1 between both countries to constitute a public health emergency of international concern under the 2005 International Health Regulations. Continued focus on identifying groups of children who missed polio vaccination through routine immunization or SIAs, improving SIA quality, and increasing AFP surveillance sensitivity in these countries is needed to stop transmission.
Related Links
Back to top
Now available! IAC's sturdy laminated versions of the 2016 U.S. child/teen immunization schedule and the 2016 U.S. adult immunization schedule—order a supply for your healthcare setting today!
IAC's laminated versions of the 2016 U.S. child/teen immunization schedule and the 2016 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Both schedules are eight pages (i.e., four double-sided pages) and are folded to measure 8.5" x 11".
Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.
PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each
For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org.
You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.
Back to top
EDUCATION AND TRAINING
Register now for the 2016 CDC webinar series on "The Pink Book" chapter topics
CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (also known as "The Pink Book"). This is a live series of one-hour webinars that starts on June 1. All sessions begin at 12:00 p.m. (ET). Information about receiving continuing education credit will be available soon.
Registration and more information is available on CDC's Pink Book Webinar Series web page.
Download Epidemiology and Prevention of Vaccine-Preventable Diseases
Order Epidemiology and Prevention of Vaccine-Preventable Diseases
Back to top
ASK THE EXPERTS
Question of the Week
An expired dose of ProQuad (MMRV, Merck) was given to a patient. We assume that the repeat dose should be given in three months because the spacing between doses of a combination vaccine depends on the longest minimum interval of a component (in this case the varicella vaccine component). Is this correct?
In the case of an expired live vaccine, the issue is not necessarily the routine minimum interval (three months in the case of varicella and ProQuad vaccines), but the interval that would prevent viral interference if the expired vaccine happened to be still viable. This interval is considered to be four weeks (28 days). The repeat dose should be administered four weeks after the expired dose.
About IAC's Question of the Week
Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.
We hope you enjoy this new feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at www.immunize.org/subscribe.
If you have a question for the CDC immunization experts, you can email them directly at nipinfo@cdc.gov. There is no charge for this service.
Related Links
Back to top
|
